Aptinyx Raises $70 Million to Expand Clinical-stage Pipeline in Therapies for Neurologic Disorders
Fibromyalgia, News
Aptinyx has completed a $70 million series B financing round to fund the expansion of its clinical-stage pipeline of therapies targeting ... Read more